More Nexalis Therapeutics Limited news
Nexalis Therapeutics LimitedASX: NX1

Lifespot Health restructures its Business and Board

Nov 1, 2017 at 12:47 AM EDT · Issued by Nexalis Therapeutics Limited

Filed with ASX · Nov 1, 2017 at 12:47 AM EDT · 2 pages · English

On 6ix: 6ix.com/news/lifespot-health-restructures-its-business-and-board

Nexalis Therapeutics Limited on 6ix

Story so far

  • Digital Health Consortium Formed To Target $3.5B MarketJul 28, 2017
  • Business & Operational UpdateMay 18, 2017
  • Lifespot Health wins major contract & strategic b2b partnerMar 8, 2017

Earlier from Nexalis Therapeutics

  • Lifespot Signs Global Agreement With BeurerSep 7, 2017
  • Digital Health Consortium Formed To Target $3.5B MarketJul 28, 2017
  • Business & Operational UpdateMay 18, 2017
  • LSH enters $50Bn Global Medicinal Cannabis marketMay 1, 2017
  • Update on Medicinal Cannabis opportunitiesApr 4, 2017

Later from Nexalis Therapeutics

  • New Patient Self-Management System LaunchedMar 20, 2018
  • Update on development of unique cannabis vaporizerApr 13, 2018
  • Amended Appendix 4C - Cash balance at 31/3 $3.904MApr 30, 2018
  • Unique cannabis vaporizer under evaluation in IsraelMay 13, 2018
  • B.Braun to launch Omnitest 5 BT with Body-TelJun 4, 2018
All Nexalis Therapeutics news releases↗

Follow Nexalis Therapeutics into a list and get an email when it puts out news.

Follow Nexalis Therapeutics
  • About 6ix
  • Editorial & Sourcing
  • Corrections
  • Contact
  • Privacy
  • Terms
  • Disclaimer